Eledon Pharmaceuticals earnings were -$5.0M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ELDN earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$11.2M, up 72.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ELDN reported annual earnings of -$36.2M, with -69% growth. The next ELDN earnings date is Nov 6, 2025.
Eledon Pharmaceuticals Earnings Reports & History FAQ
What were Eledon Pharmaceuticals's earnings last quarter?
On ELDN's earnings call on Invalid Date, Eledon Pharmaceuticals (NASDAQ: ELDN) reported Q2 2025 earnings per share (EPS) of -$0.13, up 85.87% year over year. Total ELDN earnings for the quarter were -$11.22 million. In the same quarter last year, Eledon Pharmaceuticals's earnings per share (EPS) was -$0.92.
The next ELDN earnings call is Invalid Date. Add ELDN to your watchlist to be reminded of Eledon Pharmaceuticals's next earnings date.
Is Eledon Pharmaceuticals profitable or losing money?
As of the last Eledon Pharmaceuticals earnings report, Eledon Pharmaceuticals is currently losing money. Eledon Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$5.02 million, a 95.38% decrease year over year.
What was ELDN's earnings growth in the past year?
As of Eledon Pharmaceuticals's earnings date in Invalid Date, Eledon Pharmaceuticals's earnings has grown year over year. ELDN earnings in the past year totalled -$5.02 million.
What are Eledon Pharmaceuticals's earnings expectations?
The current EPS estimate for Eledon Pharmaceuticals's earnings report in Invalid Date is -$0.25.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.